Single-cell analysis of the decidua unveils the mechanism of anti-inflammatory exosomes for chorioamnionitis in nonhuman primates
Science Advances · 04.07.2025 · 11 (27)
DOI: 10.1126/sciadv.adp0467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 04.07.2025. Verfasst von Seung Hyun Jang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Chorioamnionitis, Exosomes, Decidua, Single-Cell Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The effectiveness of exosomes engineered to carry a dominantly active variant of inhibitor α of nuclear factor κB (NF-κB) (IκBα), super-repressor IκB (srIκB), that inhibits the expression of NF-κB in various animal models of inflammatory diseases has been demonstrated. In this study, we used a lipopolysaccharide (LPS)–induced chorioamnionitis model in pregnant nonhuman primates to explore the therapeutic potential and mode of action of srIκB-loaded exosomes (Exo-srIκBs). Intraamniotic injection of LPS induced infiltration of BCL2A1-positive neutrophils and CD68-positive macrophages in the extraplacental membranes, causing fetal lung injury. Conversely, administration of Exo-srIκB via intraamniotic and intravenous routes (6.9 × 10 10 and 4 × 10 11 particle numbers, respectively) ameliorated these effects. Single-cell RNA sequencing of the decidua and bulk RNA sequencing of the choriodecidua highlighted that Exo-srIκB treatment mitigated LPS-induced inflammatory pathways, particularly in macrophages, leading to a cascade effect on neutrophils through NF-κB signaling inhibition. These findings underscore the potential of Exo-srIκB as a therapeutic strategy for chorioamnionitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Korea.
- ILIAS Biologics Inc., Daejeon, Korea.
- Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul, 03087, Korea.
- Primate Resources Center (PRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-si, Jeollabuk-do, Korea.
- Korea Institute of Ceramic Engineering and Technology, Cheongju, 28160, Korea.
ORCID-Profile: Seung Hyun Jang, Hojun Choi, Eun Mi Lee, Seung-Bin Yoon, Hye-Jung Kim, Cheolhyoung Park, Jae Kyung Won, Seung Han Shin, Ji-Su Kim, Chan-Wook Park, Heon Yung Gee, Chulhee Choi
Zitieren
APA
Jang, S. H., Choi, H., Lee, E. M., Yoon, S. B., Kim, H. J., Park, C., Won, J. K., Shin, S. H., Kim, J. S., Park, C. W., Gee, H. Y., & Choi, C. (2025). Single-cell analysis of the decidua unveils the mechanism of anti-inflammatory exosomes for chorioamnionitis in nonhuman primates. Science Advances, 11(27). https://doi.org/10.1126/sciadv.adp0467
Vancouver
Jang SH, Choi H, Lee EM, Yoon SB, Kim HJ, Park C, et al. Single-cell analysis of the decidua unveils the mechanism of anti-inflammatory exosomes for chorioamnionitis in nonhuman primates. Science Advances. 2025;11(27). doi:10.1126/sciadv.adp0467
BibTeX
@article{Jang2025,
author = {Jang, Seung Hyun and Choi, Hojun and Lee, Eun Mi and Yoon, Seung-Bin and Kim, Hye-Jung and Park, Cheolhyoung and Won, Jae Kyung and Shin, Seung Han and Kim, Ji-Su and Park, Chan-Wook and Gee, Heon Yung and Choi, Chulhee},
title = {Single-cell analysis of the decidua unveils the mechanism of anti-inflammatory exosomes for chorioamnionitis in nonhuman primates},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {27},
doi = {10.1126/sciadv.adp0467}
}
EUVIMED